With transcatheter aortic valve replacement (TAVR) becoming a mainstream procedure, worth a predicted $7.4 billion by 2025, attention is turning to the associated stroke risk. Cerebral embolic protect
Transcatheter aortic valve replacement (TAVR) is a rising alternative to surgical aortic valve replacement (SAVR) in otherwise inoperable or high-risk patients with severe aortic stenosis. Its penetra
Transcatheter aortic valve replacement (TAVR) is a rising alternative to surgical aortic valve replacement (SAVR) in otherwise inoperable or high-risk patients with severe aortic stenosis. Its penetra